Perpetual Ltd’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.1M | Sell |
5,916
-27,027
| -82% | -$27.6M | 0.1% | 122 |
|
|
2026
Q1 | $30.3M | Sell |
32,943
-1,227
| -4% | -$1.24M | 0.46% | 56 |
|
|
2025
Q4 | $36.7M | Buy |
34,170
+31,434
| +1,149% | +$30.1M | 0.53% | 46 |
|
|
2025
Q3 | $2.09M | Buy |
2,736
+1,236
| +82% | +$920K | 0.03% | 185 |
|
|
2025
Q2 | $1.17M | Buy |
1,500
+100
| +7% | +$77.7K | 0.01% | 233 |
|
|
2025
Q1 | $1.16M | Sell |
1,400
-91,771
| -98% | -$76.4M | 0.01% | 233 |
|
|
2024
Q4 | $71.9M | Sell |
93,171
-4,301
| -4% | -$3.56M | 0.84% | 44 |
|
|
2024
Q3 | $86.4M | Sell |
97,472
-4,085
| -4% | -$3.67M | 0.94% | 34 |
|
|
2024
Q2 | $91.9M | Sell |
101,557
-18,319
| -15% | -$14.7M | 1% | 31 |
|
|
2024
Q1 | $93.3M | Sell |
119,876
-31,210
| -21% | -$22.2M | 0.91% | 35 |
|
|
2023
Q4 | $88.1M | Buy |
151,086
+146,973
| +3,573% | +$85.8M | 0.91% | 33 |
|
|
2023
Q3 | $2.21M | Buy |
4,113
+426
| +12% | +$220K | 0.02% | 205 |
|
|
2023
Q2 | $1.73M | Sell |
3,687
-171
| -4% | -$71.7K | 0.01% | 253 |
|
|
2023
Q1 | $1.32M | Buy |
+3,858
| New | +$1.3M | 0.01% | 287 |
|
|
2020
Q3 | $844K | Hold |
5,700
| – | – | 0.06% | 195 |
|
|
2020
Q2 | $936K | Buy |
+5,700
| New | +$875K | 0.09% | 139 |
|
|
2020
Q1 | – | Sell |
-5,700
| Closed | -$748K | – | 215 |
|
|
2019
Q4 | $748K | Hold |
5,700
| – | – | 0.11% | 86 |
|
|
2019
Q3 | $637K | Hold |
5,700
| – | – | 0.1% | 89 |
|
|
2019
Q2 | $632K | Sell |
5,700
-2,500
| -30% | -$294K | 0.1% | 86 |
|
|
2019
Q1 | $1.06M | Hold |
8,200
| – | – | 0.15% | 73 |
|
|
2018
Q4 | $936K | Hold |
8,200
| – | – | 0.14% | 76 |
|
|
2018
Q3 | $880K | Sell |
8,200
-3,300
| -29% | -$330K | 0.12% | 82 |
|
|
2018
Q2 | $983K | Buy |
11,500
+2,100
| +22% | +$172K | 0.12% | 80 |
|
|
2018
Q1 | $727K | Hold |
9,400
| – | – | 0.1% | 82 |
|
|
2017
Q4 | $801K | Buy |
9,400
+800
| +9% | +$68.1K | 0.1% | 86 |
|
|
2017
Q3 | $741K | Hold |
8,600
| – | – | 0.1% | 84 |
|
|
2017
Q2 | $708K | Hold |
8,600
| – | – | 0.06% | 185 |
|
|
2017
Q1 | $734K | Buy |
+8,600
| New | +$689K | 0.07% | 122 |
|
|
2016
Q4 | – | Sell |
-7,147
| Closed | -$574K | – | 183 |
|
|
2016
Q3 | $574K | Sell |
7,147
-12,078
| -63% | -$967K | 0.05% | 190 |
|
|
2016
Q2 | $1.51M | Buy |
19,225
+1,200
| +7% | +$90.3K | 0.15% | 118 |
|
|
2016
Q1 | $1.3M | Sell |
18,025
-1,500
| -8% | -$113K | 0.13% | 119 |
|
|
2015
Q4 | $1.65M | Buy |
19,525
+2,600
| +15% | +$216K | 0.18% | 102 |
|
|
2015
Q3 | $1.42M | Sell |
16,925
-1,700
| -9% | -$144K | 0.17% | 101 |
|
|
2015
Q2 | $1.55M | Sell |
18,625
-2,800
| -13% | -$213K | 0.18% | 101 |
|
|
2015
Q1 | $1.56M | Hold |
21,425
| – | – | 0.18% | 102 |
|
|
2014
Q4 | $1.48M | Buy |
21,425
+800
| +4% | +$54K | 0.17% | 135 |
|
|
2014
Q3 | $1.34M | Sell |
20,625
-3,000
| -13% | -$190K | 0.14% | 128 |
|
|
2014
Q2 | $1.47M | Buy |
23,625
+3,000
| +15% | +$179K | 0.13% | 121 |
|
|
2014
Q1 | $1.21M | Sell |
20,625
-4,000
| -16% | -$223K | 0.18% | 116 |
|
|
2013
Q4 | $1.26M | Sell |
24,625
-3,339
| -12% | -$167K | 0.17% | 114 |
|
|
2013
Q3 | $1.41M | Sell |
27,964
-25,482
| -48% | -$1.33M | 0.2% | 106 |
|
|
2013
Q2 | $2.63M | Buy |
+53,446
| New | +$2.91M | 0.39% | 60 |
|
Other funds holding LLY
SC
ONB
GIM
Perpetual Ltd's LLY Position: Q2 2026 in Review
Perpetual Ltd reduced its Eli Lilly (LLY) stake by 82% in Q2 2026, selling an estimated $27.6M and leaving 5,916 shares worth $7.1M. The position accounts for 0.1% of the portfolio, ranked #122.
Perpetual Ltd first reported a position in LLY in Q2 2013 and has held it in 42 quarters since. The position peaked at $93.3M in Q1 2024. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Perpetual Ltd held 5,916 shares of Eli Lilly worth $7.1M as of Q2 2026.
- Perpetual Ltd sold 27,027 Eli Lilly shares in Q2 2026, an estimated $27.6M.
- Eli Lilly made up 0.1% of Perpetual Ltd's portfolio in Q2 2026, its #122 holding.
- Perpetual Ltd first reported a position in Eli Lilly in Q2 2013 and has held it in 42 quarters since.
- Perpetual Ltd's Eli Lilly position peaked at $93.3M in Q1 2024.
- 1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.